LakeShore Biopharma Co. L...

NASDAQ: LSB · Real-Time Price · USD
0.76
-0.03 (-3.80%)
At close: Aug 15, 2025, 12:51 PM

LakeShore Biopharma Ltd Income Statement

Financials in CNY. Fiscal year is April - March.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
Revenue
573.42M 687.2M 502.95M 257.02M
Cost of Revenue
117.69M 153.36M 117.07M 59.66M
Gross Profit
455.73M 533.84M 385.88M 197.36M
Operating Income
-445.83M -139.38M -549.18K -125.85M
Interest Income
n/a n/a n/a n/a
Pretax Income
-455.19M -144.35M -545.73K -174.37M
Net Income
-433.46M -145.48M -545.73K -191.83M
Selling & General & Admin
428.09M 333.32M 272.77M 208.33M
Research & Development
302.8M 318.7M 211.22M 94.39M
Other Expenses
170.67M -199.45K -2.41M -22.36M
Operating Expenses
901.56M 647.15M 549.18K 319.68M
Interest Expense
44.34M 30.86M 2.72M 29.69M
Selling & Marketing Expenses
280.45M 251.56M 165.72M 69.44M
Cost & Expenses
1.02B 800.51M 549.18K 379.33M
Income Tax Expense
-21.73M 1.13M 4.94M 17.45M
Shares Outstanding (Basic)
106.92M 77.42M 29.5M 28.75M
Shares Outstanding (Diluted)
106.92M 77.42M 29.5M 28.75M
EPS (Basic)
-4.05 -1.88 -0.02 -6.67
EPS (Diluted)
-4.05 -1.88 -0.02 -6.67
EBITDA
-368.66M -76.8M -67.2M -116.78M
EBIT
-410.85M -113.49M -98.35M -144.68M
Depreciation & Amortization
42.19M 36.69M 31.15M 27.91M